Skip to content

:

Articles related to focusing on healthy aging, prevention, mobility, cognition, nutrition, independence, and caregiving support.

4 min

What is the newest drug for osteoporosis? Understanding the Latest Treatments

In early September 2025, the U.S. Food and Drug Administration (FDA) approved two new biosimilars for denosumab, with Jubbonti® (denosumab-bbdz) being the most recent approval for the treatment of osteoporosis. While the reference product, Prolia, has been on the market for some time, Jubbonti represents the newest entry into the denosumab class of drugs specifically approved to treat osteoporosis.

Read Healthy Aging
4 min

How long can you be on osteoporosis meds?

An estimated one in three women and one in five men over the age of 50 will experience an osteoporotic fracture. A crucial aspect of managing this condition is understanding **how long can you be on osteoporosis meds**, as treatment duration is highly individualized and depends on the specific medication and patient risk factors.

Read Healthy Aging
4 min

Is it possible to increase bone density after 70?

Bone density naturally declines after the age of 30, with a more rapid acceleration of bone loss in women after menopause and men over 70. However, this does not mean hope is lost. It is possible to increase bone density after 70, particularly through anabolic medications, while consistent lifestyle adjustments are crucial for slowing further loss and maintaining bone strength.

Read Healthy Aging